INDIANAPOLIS, IN – March 29, 2022 — Corteva Agriscience is pleased to announce that many growers will have reinstated access to Enlist One® and Enlist Duo® herbicides for the 2022 growing season. The U.S. Environmental Protection Agency (EPA) today issued updated supplemental labels for the herbicides that remove geographic restrictions for two listed species, the American Burying Beetle and the Eastern Massasauga Rattlesnake. Enlist herbicides were granted a seven-year amended registration in January and are the first products to complete the EPA’s new Endangered Species Act (ESA) Protection risk assessment process.
“Corteva Agriscience is working on behalf of our customers to see as many labeled-off counties reinstated as possible while still protecting listed species and their habitats,” said Susanne Wasson, president, Crop Protection Business Platform for Corteva Agriscience. “American Burying Beetle and Eastern Massasauga Rattlesnake counties were prioritized because they represent the majority of restricted acres and getting them back on the label allows more growers access to this critical weed control technology for 2022.”
The updated supplemental labels remove geographic restrictions for Enlist One and Enlist Duo herbicides in 128 counties where American Burying Beetle is found, as well as six counties where Enlist Duo was restricted due to the Eastern Massasauga Rattlesnake. Updated usage area maps and supplemental labels will be available on Enlist.com/SupplementalLabels.
“Demand for this leading weed control system continues to grow and Corteva Agriscience field teams are ready to serve growers with Enlist traited crops and herbicides as we move into spring planting,” said Cynthia Ericson, vice president, U.S. Marketing for Corteva Agriscience. “Corteva Agriscience is continuing to conduct studies and provide additional data to EPA to support the removal of further geographic label restrictions where feasible.”
The Enlist® weed control system includes Enlist herbicides, Enlist™ Ahead, Enlist E3® soybeans, Enlist® cotton and Enlist® corn. The comprehensive system offers multiple herbicide modes of action to control tough weeds and is centered around 2,4-D choline with Colex-D® technology, which provides key benefits including near-zero volatility, reduced potential for off-target movement and physical drift, and improved handling characteristics when applied pursuant to label instructions. Further, Enlist cotton and Enlist E3 soybean crops are tolerant to three herbicide modes of action, 2,4-D choline, glufosinate and glyphosate, allowing for a robust integrated weed management program to tackle herbicide resistance and improve the sustainability of farmers’ weed control practices.
Corteva will also continue grower education efforts, including label changes, through the Enlist Ahead management resource, which informs growers, distributors, retailers, and applicators about proper use. The Enlist Ahead program helps customers with on-target applications and sound weed management practices for successful, sustainable use of the Enlist weed control system.
To learn more about the Enlist weed control system and see why farmers have made the switch, visit
Corteva, Inc. (NYSE: CTVA) is a publicly traded, global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world’s most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.
# # #
™ ® Trademarks of Corteva Agriscience and its affiliated companies. The transgenic soybean event in Enlist E3® soybeans is jointly developed and owned by Corteva Agriscience and M.S. Technologies, L.L.C. Enlist Duo® and Enlist One® herbicides are not registered for sale or use in all states or counties. Contact your state pesticide regulatory agency to determine if a product is registered for sale or use in your area. Enlist Duo and Enlist One are the only 2,4-D products authorized for use with Enlist® crops. Consult Enlist herbicide labels for weed species controlled. Always read and follow label directions.
Cautionary Statement About Forward-Looking Statements
This communication contains forward-looking statements and other estimates within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, 3 which are intended to be covered by the safe harbor provisions for forward-looking statements and other estimates contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like “guidance”, “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “projects,” “estimates,” “outlook,” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva’s strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures, and financial results, as well as expected benefits from, the separation of Corteva from DowDuPont, are forward looking statements. Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond Corteva’s control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Corteva’s business, results of operations and financial condition. Some of the important factors that could cause Corteva’s actual results to differ materially from those projected in any such forward-looking statements include: (i) failure to successfully develop and commercialize Corteva’s pipeline; (ii) failure to obtain or maintain the necessary regulatory approvals for some of Corteva’s products; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of Corteva’s biotechnology and other agricultural products; (iv) effect of changes in agricultural and related policies of governments and international organizations; (v) effect of competition and consolidation in Corteva’s industry; (vi) effect of competition from manufacturers of generic products; (vii) costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements; (viii) effect of climate change and unpredictable seasonal and weather factors; (ix) failure to comply with competition and antitrust laws; (x) competitor’s establishment of an intermediary platform for distribution of Corteva's products; (xi) impact of Corteva's dependence on third parties with respect to certain of its raw materials or licenses and commercialization; (xii) effect of industrial espionage and other disruptions to Corteva’s supply chain, information technology or network systems; (xiii) effect of volatility in Corteva’s input costs; (xiv) failure to raise capital through the capital markets or short-term borrowings on terms acceptable to Corteva; (xv) failure of Corteva’s customers to pay their debts to Corteva, including customer financing programs; (xvi) increases in pension and other post-employment benefit plan funding obligations; (xvii) risks related to environmental litigation and the indemnification obligations of legacy EID liabilities in connection with the separation of Corteva; (xviii) risks related to Corteva’s global operations; (xix) failure to effectively manage acquisitions, divestitures, alliances, restructurings, cost savings initiatives, and other portfolio actions; (xx) capital markets sentiment towards ESG matters; (xxi) risks related to COVID-19; (xxii) Corteva’s ability to recruit and retain key personnel; (xxiii) Corteva’s intellectual property rights or defend against intellectual property claims asserted by others; (xxiv) effect of counterfeit products; (xxv) Corteva’s dependence on intellectual property cross-license agreements; and (xxvi) other risks related to the Separation from DowDuPont.. Additionally, there may be other risks and uncertainties that Corteva is unable to currently identify or that Corteva does not currently expect to have a material impact on its business. Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Corteva’s management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement or other estimate, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements or other estimates is included in the “Risk Factors” section of Corteva’s Annual Report on Form 10-K, as modified by subsequent Quarterly Reports on Forms 10-Q and Current Reports on Form 8-K.